Answers are grounded in this paper and cite their sources.
DiGeorge syndrome and velocardiofacial syndrome are developmental disorders characterized by a wide range of congenital malformations, facial dysmorphia, endocrine and immune disorders, cognitive impairment, and neurologic and psychiatric abnormalities. Cytogenetic and molecular studies have contributed greatly to our understanding of the genetic basis of these disorders. Deletions of chromosomal region 22q11 appear to be the leading cause of DiGeorge and velocardiofacial syndrome. These studies suggest that one or more genes in this region of chromosome 22 play a major role in cardiac and craniofacial development and other derivatives of the third and fourth pharyngeal pouches, including the thymus and parathyroid glands. During the past several years there has been a tremendous effort by several groups of investigators to construct physical and transcription maps of this region to identify candidate genes. Within the next several years, we can expect that additional genes within 22q11 will be identified and that we will have a better understanding of their function and role in the development of the complex and variable phenotype of the 22q11 deletion syndrome.
No takes yet. Share an insight, caveat, or question.
Driscoll et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: